Extensile Anterior and Posterior Knee Exposure for Complete Synovectomy of Diffuse Tenosynovial Giant Cell Tumor (Pigmented Villonodular Synovitis)

Medicine & Life Sciences

• Pigmented Villonodular Synovitis 100%
• Synovectomy 89%
• Knee 52%
• Giant Cell Tumor of Tendon Sheath 37%
• Popliteal Vein 13%
• Joints 13%
• Popliteal Artery 12%
• emactuzumab 10%
• Neoplasms 10%
• Fascia 10%
• pexidartinib 9%
• Tendons 8%
• Aspirin 8%
• Femur 8%
• Sutures 8%
• Arthritis 8%
• Dissection 8%
• Adipose Tissue 7%
• Thigh 7%
• Polydioxanone 7%
• 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide 6%
• Anatomic Landmarks 6%
• Radiotherapy 6%
• Periosteum 5%
• Peroneal Nerve 5%
• Hamstring Muscles 5%
• Macrophage Colony-Stimulating Factor 5%
• Meniscus 5%
• Patella 5%
• Bone and Bones 5%
• Blood Vessels 5%
• Synovial Membrane 5%
• Osteonecrosis 5%
• Selection Bias 5%
• Recurrence 5%
• Imatinib Mesylate 5%
• Subcutaneous Tissue 5%
• Skin 5%
• Quadriceps Muscle 5%
• Knee Joint 4%
• Knee Replacement Arthroplasties 4%
• Tibia 4%
• Operative Time 4%
• Surgical Instruments 4%
• Paralysis 4%
• Ligaments 4%
• Ankle 4%
• Protein-Tyrosine Kinases 4%
• Osteoarthritis 4%
• Ligation 4%
• Magnetic Resonance Spectroscopy 3%
• Radiation 3%
• Surgeons 3%
• Aptitude 3%
• Magnetic Resonance Imaging 3%
• Muscles 2%
• Morbidity 2%
• Pain 2%
• Survival 2%
• Therapeutics 2%